Indian registry for clinical trials

Indian Journal of Medical Research

Volumn 123, Issue 5, 2006, Pages 587-590

  Satyanarayana, Kanikaram ^a   Sharma, Anju ^a   Ganguly, N K ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; PSYCHOTROPIC AGENT; ROFECOXIB; TGN 1412; UNCLASSIFIED DRUG;

ACCESS TO INFORMATION; BUDGET; CLINICAL TRIAL; DRUG INDUSTRY; DRUG RESEARCH; EDITORIAL; FACTUAL DATABASE; GOVERNMENT REGULATION; HEALTH CARE FINANCING; HEALTH CARE ORGANIZATION; HUMAN; INTERNATIONAL COOPERATION; INTERNET; LAW ENFORCEMENT; LEUKEMIA; MEDICAL ETHICS; MULTIPLE ORGAN FAILURE; OUTCOMES RESEARCH; PUBLICATION; REGISTER; RISK BENEFIT ANALYSIS; STANDARDIZATION;

CLINICAL TRIALS; HUMANS; INDIA; REGISTRIES; WORLD HEALTH ORGANIZATION;

EID: 33746113106     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Editorial

References (16)

1. Goodyear M. Learning from the TGN1412 trial. BMJ 2006; 332: 677-8.
2. Curfman GD, Morrissey S, Drazen JM. Expression of concern: Bombardier et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 2000;343:1520-8. N Engl J Med 2005; 353: 2813-4.
3. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 2004; 291: 2457-65.
4. Sim I, Chan AW, Gulmezogulu AM, Evans T, Pang T. Clinical trial registration: transparency is the watchword. Lancet 2006; 367: 1631-3.
5. Horton R. Trial registries: protecting patients, advancing trust. Lancet 2006; 367: 1633-5.
6. WHO International Clinical Trials Registry Platform. http:/www.who.int/ictrp/registration/en/; accessed on May 4, 2006.
7. Chalmers I. Underreporting research is scientific misconduct. JAMA 1990; 263: 1405-8.
8. Dickersin K, Rennie D. Registering clinical trials. JAMA 2003; 290: 516-23.
9. Simes RJ. The case for an international registry of clinical trials J Clin Oncol 1986; 4: 1529-41.
10. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et.al. Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 2005; 352: 2436-8.
11. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et. al. Clinical trial registration: A statement from the International Committee of Medical Journal Editor. JAMA 2004; 292: 1363-4.
12. Krleza-Jeric K, Chan AW, Dickirsin K, Sim I, Grimshaw J, Gludd C. Principles for international collaboration in setting up standards for clinical trial registration. Lancet 2005: 365: 1829-31.
13. The World Health Organization announces new standards for registration of all human medical research 19 May, 2006 http://www.who.int/mediacentre/news/releases/2006/pr25/en/index.html; accessed on May 20, 2006.
14. http://www.phrma.org/news_room/press_releases/ r%26d_investments_by_america%92s_pharmaceutical_ research_companies_nears_records_%2440_billion_in_2005/ (accessed on May 5, 2006)
15. Gitanjali B. ICMJE statement on compulsory clinical trial registration: Should Indian journals follow suit? Indian J Pharmacol 2005; 37: 207-8.
16. Mudur G. Indian plans to audit clinical trials BMJ 2005; 331: 1044.